​

Introduction to TMS Therapy

Non-invasive, non-pharmaceutical, FDA cleared 

 

TMS has been recommended by the American Psychiatric Association since 2010 for the treatment of major depressive disorder. 

TMS Therapy is free from common antidepressant drug side effects such as weight gain and sexual dysfunction. It is a non-invasive treatment, and does not require anesthesia. TMS is not to be confused with ECT (Electroconvulsive Therapy), and it does not affect cognitive function such as memory.  Patients may resume daily activities right after treatment.  

We also offer iTBS for self pay patients.

​​

• FDA cleared* 

• Integrable solution

• Express TMS: 3 min sessions

• Covered by most insurance

• Proven track-record

   •  Does not affect cognitive function

   •  No anesthesia 

 

Are you or a loved one struggling with major depression? Have you obtained no or inadequate relief from antidepressants, or is it difficult for you to tolerate the side effects such as weight gain, insomnia, and sweating? Then maybe MagVenture TMS Therapy could be the solution for you.

​

The MagVenture TMS Therapy procedure 

• An initial session where the patient's individual stimulation level (also known as motor threshold) is determined 

• 5 treatment sessions per week during a period of normally 4-6 weeks.

• The duration of a standard TMS treatment session is  between 19-37 minutes. In 2018, MagVenture also received FDA clearance for a newer, and much faster protocol called Express TMS. This procedure is similar to standard TMS  but a session only lasts 3 minutes. 

• Maintenance treatment if needed.

 

Why Should I consider TMS, I take medication?

​

Medication treatment of depression and anxiety is ​an effective modality to treat these conditions. If you are already taking medications then you are aware of the side effects of medication and the extended nature of the need for c​ontinued administration of the medication to maintain symptoms or the need to adjust or change medications to achieve remission.

In 6 weeks TMS can potentially achieve what medication can do in months or maybe years. the outcome may well be that you will not need medication any longer to control the depressive and anxiety symptoms.

​

What is Buprenorphine?

​

Buprenorphine is an opioid partial agonist. This means that, although buprenorphine is an opioid, and thus can produce typical opioid agonist effects and side effects such as euphoria and respiratory depression, its maximal effects are less than those of full agonists like heroin and methadone. At low doses buprenorphine produces sufficient agonist effect to enable opioid-addicted individuals to discontinue the misuse of opioids without experiencing withdrawal symptoms. The agonist effects of buprenorphine increase linearly with increasing doses of the drug until at moderate doses they reach a plateau and no longer continue to increase with further increases in dose—the “ceiling effect.” Thus, buprenorphine carries a lower risk of abuse, addiction, and side effects compared to full opioid agonists. In fact, in high doses and under certain circumstances, buprenorphine can actually block the effects of full opioid agonists and can precipitate withdrawal symptoms if administered to an opioid-addicted individual while a full agonist is in the bloodstream.

​

Substance Use Disorders (Buprenorphine therapy)

​

Buprenorphine (Suboxone) is a proven medication for treatment of opiate addiction and can replace methadone and older treatment options with major decrease in cravings and return to a healthier lifestyle. 

 

The beneficial effects of Opioid addiction therapy will be most noticeable in individuals who have been objectively diagnosed with opioid addiction, are willing to follow safety precautions for treatment, can be expected to comply with the treatment, have no contraindications to buprenorphine therapy, and who agree to buprenorphine treatment after a review of treatment options.

​

Substance use is a debilitating condition that affects the individual in many ways. It is frequently a form of self medication to combat a variety of medical and psychiatric conditions including physical and mental pain. Mental pain usually stems from depression and anxiety disorder spectra.  The substance frequently becomes a major concern and takes efforts away from dealing with the primary cause to combat the substance use itself.

​

Effective treatment of drug addiction requires comprehensive attention to all of an individual’s medical and psychosocial co-morbidities. Pharmacological therapy alone rarely achieves long-term success.

​

​